Structure Therapeutics Inc.

601 Gateway Blvd., Suite 900

South San Francisco, CA 94080

 

November 27, 2023

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn:

Joshua Gorsky

 

Re:	Structure Therapeutics Inc.
	Registration Statement on Form S-1
	Filed November 17, 2023
	File No. 333-275651
	Acceleration Request
	Requested Date: November 29, 2023
	Requested Time: 4:00 p.m. Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Structure Therapeutics Inc. hereby requests that the U.S. Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern Time, on November 29, 2023, or as soon thereafter as practicable.

 

Once the Registration Statement has been declared effective, please orally confirm that event with Patrick Loofbourrow of Cooley LLP at (619) 840-4824, or in his absence, Carlos Ramirez of Cooley LLP at (858) 550-6157.

 

Sincerely,

 

Structure Therapeutics Inc.

 

By:	/s/ Raymond Stevens
	Raymond Stevens, Ph.D.
	Chief Executive Officer